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Abstract - Virtual drug screening is one of the most widely 
used approaches for finding new drugs candidates. The 
process consists in selecting one or more chemical compounds 
with the highest binding free energy to target proteins. Given 
that the empirical space of chemical compounds is extremely 
large and estimated to has over 50 millions of them, finding 
the most effective drug becomes computationally challenging. 
Furthermore, the vast majority of proteins still lack the 
experimentally obtained 3D structures required for most of 
the molecular computer tools available, making it impossible 
to calculate their binding free energies with chemical 
compounds. In view of this, the aim of our study is to asses 
the effectiveness of the Autodock Vina tool in a large 
environments with unstructured proteins, those without 
defined 3D structure. The ultimate goal is to enable a fast and 
efficient virtual drug screening in such an environments, and 
to apply it for discovery of a new drug candidates. 
Keywords - Autodock Vina; virtual drug screening; drug 
discovery; binding free energy; unstructured proteins 
I. INTRODUCTION 
Virtual screening is a computer technique often used in 
finding new drugs [1]. Virtual screening approaches, 
including ligand based ones, have been used in the 
discovery of Janus kinase 2 (JAK2) inhibitors. Developing 
JAK2 inhibitors has become a significant focus for small 
molecule drug discovery programs in recent years because 
the inhibition of JAK2 may be an effective approach for the 
treatment of polycythemia vera, primary myelofibrosis and 
essential thrombocythemia. Yang and colleagues reported 
a strategy using virtual screening approaches that can be a 
starting point for development of novel JAK2 inhibitors 
with high potency and selectivity [2]. A promising results 
were reported by Viegas and associates, emphasizing 
importance of virtual screening as a useful strategy to 
prospect active compounds, showing satisfactory 
pharmacokinetic and toxicological profiles respectively. 
They have presented novel anti Herpes simplex virus 1 
(HSV-1) compounds which can be used for development of 
new drugs for the treatment of HSV-1 infections with 
different modes of action than acyclovir [3]. Results from a 
study from Lim et al. showed also encouraging results in 
field of Hepatitis C virus (HCV) helicase inhibitors, 
revealing 10 potential drugs discovered via a new docking 
optimization protocol with better docking accuracy [4]. 
Their findings could contribute to the discovery of novel 
HCV antivirals, serving as an alternative approach of in 
silico rational drug discovery. 
 In doing so, libraries [5] containing the structures of small-
molecules whose molecular weight is less than 900 Daltons 
(in further text referred as compounds), are searched in 
order to identify those compounds that have the highest free 
energy of binding with target molecules. These target 
molecules are most commonly proteins and enzymes. 
While some compound libraries like PubChem already 
contain molecular structures [6], others are based on make-
on-demand creation of compound structures, e.g. from 130 
well-characterized chemical reactions [7]. However, in 
both cases, a fast and effective search and processing of 
libraries consisting of thousands and even tens of millions 
of compounds is required. This poses a significant 
challenge, both in terms of the required computing 
resources and the accuracy of the results obtained [8]. 
Although artificial neural networks coupled with deep-
learning techniques promote the dramatic reduction of 
computing resources required for virtual drug screening 
[9], there is still a work to match their accuracy with a 
structure-based tools. The computation of the free binding 
energy between protein and compound is usually 
performed in three steps. In the first step protein and 
compound structures are prepared for docking and docking 
site on the protein surface is identified. As the next, docking 
between protein and compound is performed. Final step is 
scoring,  where binding free energy between protein and 
compound is calculated [10]. There are several dozens of 
docking tools available, with various implementations of 
their scoring function [11]. The accuracy of docking and 
scoring varies from tool to tool, and is also conditioned by 
the structure of the protein and compound [12]. Higher 
accuracy in the computation of binding free energy can be 
achieved through the use of molecular dynamics (MD) 
computer programs [13]. However, due to the high demand 
on computational resources, their use in virtual drug 
screening on a large data sets is still prohibitive [14]. 
Another problem with structure-based virtual drug 
screening is that docking tools demand the existence of 
well-defined 3D protein structures (in the further text 
referenced as structured proteins). RCSB portal [15] is 
usually searched for these structures. But, there are much 
more proteins without the structure (in the further text 
referenced as unstructured proteins), then structured 
proteins. During the preparation of this paper, and 
according to the statistics on RCSB portal, there was near 
150.00 protein structures available. However, many of 
them are redundant, as they describe the same protein in 
complex with different compounds. Because of that,  the 
total number of structured proteins is smaller and is 
currently near  10.000. This is by far less than the estimated 
number of different proteins in the human genome, which 
according to some sources equals about 80.000 [16]. In 
order for virtual drug screening to be performed on 
unstructured proteins, one needs to predict their structures 
from their respective amino acid sequences [17]. 
Furthermore, some protein structures are complete as they 
have spatial coordinates defined for every atom in the 
protein, while others have coordinates for only a fraction of 
them. This is called the completeness.  In addition, different 
structures for the same protein may have different 
resolution levels dependent on which method for obtaining 
the structure was applied (NRM spectroscopy, X-ray 
crystallography, X-ray free electron lasers, 3D electron 
microscopy). Besides, the number of structures describing 
proteins without compounds is relatively small compared 
to the number of structures describing proteins in complex 
with one or more compounds. And because compounds 
cause a deformations on protein surface, it is of the 
advantage to take structures without compounds. 
Therefore, for the best possible accuracy of virtual drug 
screening, one needs to take protein structures with highest 
completeness and resolution, and with the lowest number 
of compounds. Afterall,  if compounds are present in the 
structure, one needs to remove them. The next step is to 
prepare the protein and compound structures. The  most 
crystal structures on RCSB portal are missing residues [18], 
so they need to be added before docking and scoring. 
Furthermore, hydrogen atoms in protein and compound 
structures must be added, partial charges assigned, missing  
loops  filled,  and the  protein structures minimized to 
relieve steric clashes [19] [20]. On the other hand, if we 
have unstructured proteins, it is advisable to predict their 
structures as accurately as possible. And once a virtual drug 
screening is launched, it should be performed without 
interruption and human intervention, until the very end. All 
relevant information should be recorded for the later 
analysis and possible corrections. A good example of how 
a virtual drug screening process should be conducted is 
found in [21]. 
II. MATERIALS AND MEHODS 
We used the Vini in silico model of cancer [22] for testing 
the accuracy of Autodock Vina performing docking on 
large datasets with unstructured proteins.  The main reason 
for this choice is the fact that the VINI model has already 
implemented virtual drug screening workflow, and the 
software necessarry for selecting the best protein structures, 
preparing them, and predicting the high-quality structures 
for unstructured proteins. The VINI model uses UCSF 
Chimera [23], MGLTools [24], Autodock Vina [25], and 
Open Babel [26] for virtual drug screening. In addition, it 
has its own modules to support virtual drug screening 
workflow. These are create_completeness_list module for 
selecting and retrieving the best RCSB protein structures, 
prepare_protein module for preparing protein structures for 
docking, and predict_protein_structure module for 
selecting and retrieving predicted protein structures from 
the SWISS-MODEL [27] repository. For the testing 
purposes, we used part of the experimentally obtained data 
from the IDG-Dream Drug-Kinase Binding Prediction 
Challenge [28], aimed at accurately predicting the binding 
intensity between protein kinase inhibitors [29] and target 
proteins. We obtained this information in the form of a list 
of 5329 pairs of protein kinase inhibitors and target 
proteins, with experimentally measured values of binding 
free energy expressed with pkd values, where pkd is 
defined as: 
 
𝑝𝑘𝑑 = −1000 log (𝐾𝑑)                                               (1) 
 
Kd in (1) is the dissociation constant, measuring the 
propensity of a larger object to separate (dissociate) 
reversibly into smaller components. The relation between 
the binding free energy ΔG and the dissociation constant is 
defined as [30]: 
 
𝛥𝐺 = 𝑅 𝑇 log (𝐾𝑑)                                                             (2) 
 
where R is gass constant and has a value 8.3145 J/mol·K, 
while T is the temperature at which the experiments were 
performed and is 293 Kelvin. By including Kd from (1) into 
(2), it follows: 
 
ΔG= - (pkd R T) / 1000                                                        (3)                                                                                                                                                 
 
Further on, we decided to use mean absolute error (MAE) 
instead of root mean square error (RMSE) in our analysis. 
MAE provides us with physically more understandible 
interpretation of data then it RMSE does. The advantage of 
using MAE over RMSE in evaluating the mean 
performance of the model is given in [31]. For the total of  
M pairs with structured proteins and N pairs with 
unstructured proteins, MAE can be expressed as 
  
MAEe =
1
𝑀
∑ |𝛥𝐺𝑒(𝑚) − 𝛥𝐺𝑐(𝑚)|
𝑀
𝑚=1
                         (4) 
 
for the experimentally obtained protein structures, and 
 
MAE𝑝 =
1
𝑁
∑ |𝛥𝐺𝑒(𝑛) − 𝛥𝐺𝑐(𝑛)|𝑁𝑛=1                              (5) 
 
for the predicted protein structures, where ΔGe(m) and  
ΔGc(m)  are measured and computed binding free energy 
values for pairs with structured proteins, and ΔGe(n) and 
ΔGc(n)  are measured and computed binding free energy 
for pairs with unstructured proteins. In the case of accurate 
prediction of all protein structures, MAEe equals MAEp, 
but due to the limited prediction accuracy of SWISS-
MODEL, the following inequality applies: 
 
MAEe < MAEp                                                               (6) 
                                                                                                                                                              
From (4) and (5), and considering (6), one can define the 
average quality of the N predicted structures as: 
 
𝑞(𝑁) = 100 
𝑀𝐴𝐸𝑒
𝑀𝐴𝐸𝑝
  ; subject to MAEe < MAEp           (7)                                                                                                                                
 
Defined in such a way, q(N) will have a value of 100 if all 
N protein structures are predicted accurately (MAEp = 
MAEe), will decrease with lower prediction accuracy 
(MAEp >  MAEe), and has near zero value if the prediction 
is bad ( (MAEp >> MAEe). Equation (7) was used to 
evaluate the accuracy of binding free energy calculations 
using predicted protein structures versus binding free 
energy calculations using experimentally established 
protein structures. The VINI model carried out virtual drug 
screening without human intervention from start to end, in 
three separate stages. First, protein and compound 
structures were prepared, then binding and binding free 
energy calculation for each pair was performed. Finally, 
MAEe and MAEp were computed. In addition to 
calculating the free binding energy for  protein-compound 
pairs given by the IDG-Dream Drug-Kinase Binding 
Prediction Challenge, the VINI model also calculated the 
free binding energy for all other possible protein-compound 
In total, the VINI model calculated the binding energy for 
34,748 protein-compound pairs using 96 processor cores 
over a 27-hour period. 
The virtual drug screening process for each protein-
compound pair is shown schematically in Figure 1. 
 
Figure 1. Overview of a virtual drug screening procedure for a 
particular protein-compound pair. 
The VINI model repeated this procedure for each protein-
compound pair, in two stages. In the first stage, it selected 
and prepared the experimentally determined protein 
structures. In case the protein structure did not exists, the 
model performed the structure prediction. In the next stage, 
the VINI model performed binding between proteins and 
compounds, and the binding free energy calculations. 
 
a) Preparation of protein structures 
In this initial stage of virtual screening, the VINI model 
tried to select and prepare protein structures. 238 compound 
structures from the CHEMBL base [32] were prepared 
already before, by converting their smiles to pdb format, 
and by adding hydrogen atoms to them. The VINI model 
identified 151 proteins from the Uniprot base [33] among 
Figure 2. Heatmap of experimental value for failed protein-compound pairs 
5329 protein-compound pairs. Among them, 136 were 
structured, and 25 unstructured proteins. For unstructured 
proteins, the VINI model attempted to find and retrieve 
predicted structures in the SWISS-MODEL repository with 
the highest estimated quality using the QMEAN rating [34]. 
For the 5 unstructured proteins, the VINI model could not 
find the predicted structures, and omitted them from the 
further analysis. In case of a structured proteins, for each 
such protein the VINI model attempted to select and obtain 
from the RCSB database the structure with the highest 
completeness. The next step was to remove water 
molecules and ligands from that structure, and then to add 
partial charges [35], hydrogen atoms to polar bonds [36], 
and missing residues. In doing so, the VINI model used the 
Dock Prep module of the UCSF Chimera software, the 
prepare_receptor4 module of the MGLTools software 
package, and the Open Babel software. If an error occurred 
during the preparation of the protein structure, the VINI 
model attempted to prepare the next structure with the next 
lower QMEAN. The process was repeated until some 
structure was sucesfully prepared for docking, or until the 
preparation of all available structures failed. If no structure 
could be prepared for docking, the Vini model additionally 
tried to prepare the predicted structure for docking. If this 
also failed, the VINI model dropped all the protein-
compound pairs referencing that protein from further 
analysis. For 231 protein-ligand docking pairs from a total 
of 5329, the simulation could not be performed due to the 
limitation of used tools for seven protein structures 
with Uniprot_ID's P49760 (35), P14616 (35), P49336 (33), 
Q8NE63 (32), Q9H2X6 (32), Q9H422 (32) and Q8IY84 
(32). Experimental values for failed pairs are presented in 
Figure 2. The average experimental (affinity) value for the 
'failed' docking pairs is -7.439 kcal/mol with a standard 
deviation of 1.127, while the median is -6.817803 with 148 
pairs having the same experimental value. 
b) Binding and binding free energy calculations 
At this stage, the VINI model performed docking between 
proteins and compounds, and calculated free binding 
energies betwen them. The size of the simulation box was 
set to 40 Angstroms for all pairs. The spatial coordinates of 
the docking positions were calculated using the AutoGrid4 
module from MGL Tools. Docking simulations and 
binding free energy calculations were performed with the 
Autodock Vina. In case the docking between protein and 
compound failed, the VINI model dropped that pair from 
further analysis. 
Finally, the VINI model calculated the MAEe value of  
binding free energy for pairs with structured proteins by 
using (4), and the MAEp value of free binding energies for 
pairs with unstructured proteins by using (5). 
III. RESULTS AND DISCUSSION 
In total, 5329 protein-compound pairs from the Grand 
Challenge data set were analyzed. Binding free energy was 
calculated for 3979 pairs with structured proteins, 1119 
pairs with unstructured proteins, while the binding free 
energy of 231 pairs was not calculated, either as they 
contained proteins whose predicted structure was not found 
in the SWISS-MODEL repository, or the binding 
simulation failed. For pairs with structured proteins, the 
mean experimentally determined binding free energy was  
-7.61201 kcal/mol and the mean calculated binding free 
energy was –7.21033 kcal/mol. MAEe size of 0.40168 
kcal/mol was calculated. For pairs with unstructured 
proteins, the mean of experimentally determined binding 
free energies was -7.58098 kcal/mol and the mean of 
computed binding free energies was -6.99009 kcal/ mol. 
MAEp of 0.59089 kcal/mol was calculated. In Figure 3, we 
show  for each protein-compund pair its corresponding 
MAE. In addition, in Figure 4 we show histogram 
distributions of corresponding MAE for experimentally 
determined (E) and predicted protein structures (P) with 
median values of 0.897803 and 0.931364, respectively. 
From (7) calculated mean quality factor q(N) of 25 
predicted protein structures was 67.9. This value is in a 
good agreement with the average IDDT test result [37] on 
the CAMEO portal [38] of 65.5 for 65 protein structures 
predicted by SWISS-MODEL. 
Significant deviation of the computed binding free energy 
relative to the experimentally determined value has been 
obtained for multiple pairs, and the largest absolute error 
was identified for the pair with Q15349 protein and   
CHEMBL191003 compound, -8.70 kcal/mol. 
 
Figure 3. Mean absolute error distribution for pairs with 
experimentally determined (E) and predicted (P) protein 
structure 
 
Besides the virtual drug screening of 5329 pairs, we let 
VINI model to perform simulation run on first 1000 pairs, 
and perform it 10 times. The rationale behind was to find 
out how well the results for the same pairs dissipate around 
a certain mean value. The results of this runs are shown in 
Figure 5. 
 
 Figure 4. Histogram distributions of mean absolute error for 
pairs with experimentally determined (E) and predicted (P) 
protein structure 
 
The relatively small MAE was found relatively small, both 
for pairs with structured and unstructured proteins, thus 
indicating that the Autodock Vina is a good tool for initial 
virtual drug screening on a large data sets. On the other 
hand, large and relatively frequent absolute errors indicate 
that Autodock Vina in some cases gives a false estimate of 
the binding free energy. For this,  it is advisable to re-check 
all drug candidates resulting from initial virtual drug 
screening on a large datasets with more accurate molecular 
MD tools. However, it should be kept in mind that MD 
tools put high demand on computer resources.   Therefore, 
in the final screening the number of drug candidates must 
be appropriate to the available computer resources. The 
q(N) value of 67.9 obtained in this experiment overhelmes 
the  accuracy of  the ten docking programs, including the 
Autodock Vina tool [39]. Therefore, it seems appropriate to 
use the predicted protein structures in the virtual drug 
screening process. On the other hand, their use by much 
more accurate MD tools seems still to be prohibitive and 
deserves the future research. 
 
Regarding some very high absolute errors found in this 
experiment, one possible cause may be that many of the 
compounds in the experimental dataset were large 
molecules with a molecular mass > 900 Daltons,  and  Vina 
is not built to work with a large ligands. Another possible 
cause of such major errors is that many compounds in the 
test datasheet are biotech drugs, and Vina was not trained 
on them. Notwithstanding the relatively large individual 
errors in the calculation of free binding energies, the test 
results show that the predicted structures contribute very 
little to reducing the accuracy of the results. Furthermore, 
the results obtained show that SWISS-MODEL predicts  
protein structures that may be used in docking programs. 
The possible cause of relatively high absolute errors 
between experimental and computed value may also rest  in 
3D structures of the compounds of the experimental 
dataset. Concretely, the IDG-Dream Drug-Kinase Binding 
Prediction Challenge delivered the description of the 
compounds in SMILES [40] data format. Smiles were 
converted to 3D structures with Open Babel and delivered 
to us.. Based on our previous research and the experience, 
Open Babel conversion from smiles format to 3D structures 
is not be the best solution and may introduce a certain 
amount of errors in the obtained structures. However, this 
part is beyond the research scope of this paper. Based on 
the results obtained, our conclusion is that it is justified to 
use the predictive structures in virtual drug screening of a 
large datasets containing unstructured proteins. We bexpect 
that with a more accurate 3D structures of compounds, the 
absolute error values will be considerably lover. This will 
be a part of our future research.   
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